This evening event profiles the bench to bedside progress of the Cima Lab's efforts targeting tumor oxygen levels as a vulnerability in cancer. Through innovative prototyping and clinical trials, researchers have developed a responsive sensor to sample and relay information about oxygen levels that can inform treatment decisions to dramatically affect how tumors respond to radiation therapy. Discover the ins and out of personalized treatment and learn how the team is drawing on resources across the research spectrum to improve cancer treatment and patient outcomes.
Featured Presenters:
Michael Cima, PhD
David H. Koch (1962) Professor of Engineering
Professor of Materials Science and Engineering
Associate Dean of Innovation
Co-founder, Stratagen Bio
Gregory Ekchian, PhD
Postdoctoral Fellow, Koch Institute at MIT
Blavatnik Fellow, Harvard Business School
Co-founder and CEO, Stratagen Bio
Presented as part of the Koch Institute's tenth anniversary celebrations
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
500 Main Street, Building 76
Cambridge MA, 02139-4307
617-253-6403